Specifically, apremilast has been shown to improve oxidized LDL-induced endothelial dysfunction by restoring Krüppel-like-factor-6 expression and has beneficial metabolic effects, suggesting a potential role for apremilast in improving cardiovascular function [47,48]. The gene discussed is KLF6; the disease is endothelial dysfunction.